BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21304097)

  • 1. Mortality implications of primary percutaneous coronary intervention treatment delays: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction trial.
    Hudson MP; Armstrong PW; O'Neil WW; Stebbins AL; Weaver WD; Widimsky P; Aylward PE; Ruzyllo W; Holmes D; Mahaffey KW; Granger CB
    Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):183-92. PubMed ID: 21304097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study.
    Shiomi H; Nakagawa Y; Morimoto T; Furukawa Y; Nakano A; Shirai S; Taniguchi R; Yamaji K; Nagao K; Suyama T; Mitsuoka H; Araki M; Takashima H; Mizoguchi T; Eisawa H; Sugiyama S; Kimura T;
    BMJ; 2012 May; 344():e3257. PubMed ID: 22623632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction.
    McNamara RL; Wang Y; Herrin J; Curtis JP; Bradley EH; Magid DJ; Peterson ED; Blaney M; Frederick PD; Krumholz HM;
    J Am Coll Cardiol; 2006 Jun; 47(11):2180-6. PubMed ID: 16750682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of an audit program and other factors on door-to-balloon times in acute ST-elevation myocardial infarction patients destined for primary coronary intervention.
    Lai CL; Fan CM; Liao PC; Tsai KC; Yang CY; Chu SH; Chien KL
    Acad Emerg Med; 2009 Apr; 16(4):333-42. PubMed ID: 19456296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of door-to-activation time on door-to-balloon time in primary percutaneous coronary intervention for ST-segment elevation myocardial infarctions: a report from the Activate-SF registry.
    McCabe JM; Armstrong EJ; Hoffmayer KS; Bhave PD; MacGregor JS; Hsue P; Stein JC; Kinlay S; Ganz P
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):672-9. PubMed ID: 22949494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between symptom-onset-to-balloon time and long-term mortality in patients with acute myocardial infarction treated with drug-eluting stents.
    Cho YW; Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DI; Lee SH; Cho YK; Kim DS
    J Cardiol; 2011 Sep; 58(2):143-50. PubMed ID: 21764561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model for predicting mortality in acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: results from the Assessment of Pexelizumab in Acute Myocardial Infarction Trial.
    Stebbins A; Mehta RH; Armstrong PW; Lee KL; Hamm C; Van de Werf F; James S; Toftegaard-Nielsen T; Seabra-Gomes R; White HD; Granger CB;
    Circ Cardiovasc Interv; 2010 Oct; 3(5):414-22. PubMed ID: 20858863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of importance of door-to-balloon time and total ischemic time in acute myocardial infarction with ST-elevation treated with primary percutaneous coronary intervention.
    Heitzler VN; Babić Z; Milicić D; Starcević B; Mirat J; Strozzi M; Plazonić Z; Giunio L; Steiner R; Vuković I; Bernat R; Pintarić H
    Acta Clin Croat; 2012 Sep; 51(3):387-95. PubMed ID: 23330404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte.
    Zahn R; Vogt A; Zeymer U; Gitt AK; Seidl K; Gottwik M; Weber MA; Niederer W; Mödl B; Engel HJ; Tebbe U; Senges J;
    Heart; 2005 Aug; 91(8):1041-6. PubMed ID: 16020592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial.
    Blankenship JC; Skelding KA; Scott TD; Berger PB; Parise H; Brodie BR; Witzenbichler B; Gaugliumi G; Peruga JZ; Lansky AJ; Mehran R; Stone GW
    Am J Cardiol; 2010 Dec; 106(11):1527-33. PubMed ID: 21094350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: timing, characteristics, and clinical outcomes.
    Guptill JT; Mehta RH; Armstrong PW; Horton J; Laskowitz D; James S; Granger CB; Lopes RD
    Circ Cardiovasc Interv; 2013 Apr; 6(2):176-83. PubMed ID: 23549644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis.
    Nallamothu BK; Bates ER; Herrin J; Wang Y; Bradley EH; Krumholz HM;
    Circulation; 2005 Feb; 111(6):761-7. PubMed ID: 15699253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase.
    Pinto DS; Frederick PD; Chakrabarti AK; Kirtane AJ; Ullman E; Dejam A; Miller DP; Henry TD; Gibson CM;
    Circulation; 2011 Dec; 124(23):2512-21. PubMed ID: 22064592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct ambulance transport to catheterization laboratory reduces door-to-balloon time in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the DIRECT-STEMI study.
    Qiu JP; Zhang Q; Lu JD; Wang HR; Lin J; Ge ZR; Zhang RY; Shen WF
    Chin Med J (Engl); 2011 Mar; 124(6):805-10. PubMed ID: 21518584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nationwide improvement of door-to-balloon times in patients with acute ST-segment elevation myocardial infarction requiring primary percutaneous coronary intervention with out-of-hospital 12-lead ECG recording and transmission.
    Ong ME; Wong AS; Seet CM; Teo SG; Lim BL; Ong PJ; Lai SM; Ong SH; Lee FC; Chan KP; Anantharaman V; Chua TS; Pek PP; Li H
    Ann Emerg Med; 2013 Mar; 61(3):339-47. PubMed ID: 23021348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the time to reperfusion on early outcomes in patients with acute myocardial infarction undergoing primary angioplasty.
    Trzos E; Kurpesa M; Bednarkiewicz Z; Peruga J; Kasprzak J; Plewka M; Uznańska B; Krzemińska-Pakuła M
    Kardiol Pol; 2007 Nov; 65(11):1296-304; discussion 1305-6. PubMed ID: 18058580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of different clinical pathways on outcomes of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: the RAPID-AMI study.
    Zhang Q; Zhang RY; Qiu JP; Jin HG; Zhang JF; Wang XL; Jiang L; Liao ML; Hu J; Ding FH; Zhang JS; Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):636-42. PubMed ID: 19323926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for improving arrival-to-electrocardiogram time in emergency department chest pain patients and the effect on door-to-balloon time for ST-segment elevation myocardial infarction.
    Takakuwa KM; Burek GA; Estepa AT; Shofer FS
    Acad Emerg Med; 2009 Oct; 16(10):921-7. PubMed ID: 19754862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of onset-to-door time and door-to-balloon time on mortality in patients undergoing percutaneous coronary interventions for st-segment elevation myocardial infarction.
    Hannan EL; Zhong Y; Jacobs AK; Holmes DR; Walford G; Venditti FJ; Stamato NJ; Sharma S; King SB
    Am J Cardiol; 2010 Jul; 106(2):143-7. PubMed ID: 20598994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.